Literature DB >> 25387541

Open questions in the treatment of cancer pain: time for a strong evidence-based approach?

Silvia Natoli1, Marzia Lazzari, Mario Dauri.   

Abstract

Pain affects patients with cancer at any stage of their disease. Yet, it is not adequately treated in a significant percentage of cases. In 1986, the WHO proposed a three-step approach for the treatment of pain in cancer patients (from nonopioids to weak opioids to strong opioids, according to pain intensity) following the recommendations of an international group of experts. The application of the WHO strategy demonstrated that a clear and simple approach is of educational value and ensured worldwide dissemination. However, there is little evidence that the WHO approach is the best, and there are still several points to debate on the treatment of cancer pain.

Entities:  

Keywords:  WHO guidelines; cancer pain; evidence-based approach; opioids

Mesh:

Substances:

Year:  2014        PMID: 25387541     DOI: 10.1517/14656566.2015.980724

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  3 in total

Review 1.  Updates in palliative care - overview and recent advancements in the pharmacological management of cancer pain.

Authors:  Helen Wood; Andrew Dickman; Angela Star; Jason W Boland
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

Review 2.  Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review.

Authors:  Cathy L Carlson
Journal:  J Pain Res       Date:  2016-07-22       Impact factor: 3.133

3.  Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation.

Authors:  Marzia Lazzari; Claudio Marcassa; Silvia Natoli; Roberta Carpenedo; Clarissa Caldarulo; Maria B Silvi; Mario Dauri
Journal:  Clin Interv Aging       Date:  2016-05-13       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.